Literature DB >> 3381875

Bronchoalveolar lavage in an animal model of acute lung injury. Relationship between enhanced membrane permeability and transvascular neutrophil flux.

F L Glauser1, D E Bechard, B J Fisher, D Davis, A A Fowler.   

Abstract

Results of studies utilizing bronchoalveolar lavage (BAL) have led workers to propose that the neutrophil serves as the pivotal cellular element responsible for promoting enhanced alveolar capillary membrane (ACM) permeability in certain forms of acute lung injury. The authors performed BAL on anesthetized, intubated, instrumented sheep before and after the administration of 15 mg/kg ethchlorvynol, a known pulmonary edemagenic agent. Bronchoalveolar lavage fluid (BALF) protein content increased from 0.62 +/- 0.05 to 1.5 +/- 0.15 mg/ml, and the percentage of neutrophils recovered from 2% +/- 1% at baseline to 35% +/- 7% (P less than 0.01) 60 minutes after infusion of ethchlorvynol. After ethchlorvynol infusion into neutropenic sheep (less than 500 cells/microliter), BALF protein content increased from 0.35 +/- 0.08 to 1.5 +/- 0.69 mg/ml (P less than 0.01) with no increase in BALF neutrophil count. In 3 non-neutropenic sheep BAL was performed at 15 and 30 minutes after ethchlorvynol infusion. BALF protein content increased significantly within 15 minutes, whereas the percentage of neutrophils did not change. These findings suggest coexistent ACM injury as reflected by increases in BALF protein content and increased number of neutrophils in BALF does not necessarily imply a cause-and-effect relationship in certain forms of acute lung injury.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3381875      PMCID: PMC1880710     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  18 in total

1.  The effects of ethchlorvynol on pulmonary alveolar membrane permeability.

Authors:  P Fischer; F L Glauser; J E Millen; J Lewis; P Egan
Journal:  Am Rev Respir Dis       Date:  1977-11

2.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

3.  The adult respiratory distress syndrome. Cell populations and soluble mediators in the air spaces of patients at high risk.

Authors:  A A Fowler; T M Hyers; B J Fisher; D E Bechard; R M Centor; R O Webster
Journal:  Am Rev Respir Dis       Date:  1987-11

4.  Increases in lung lymph and albumin clearance with ethchlorvynol.

Authors:  R P Fairman; F L Glauser; R Falls
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1981-06

5.  Ethchlorvynol-induced pulmonary edema in rats. An ultrastructural study.

Authors:  R Wysolmerski; D Lagunoff; T Dahms
Journal:  Am J Pathol       Date:  1984-06       Impact factor: 4.307

6.  Quantitation of leukocytes in bronchoalveolar lavage samples from rats after intravascular injection of endotoxin.

Authors:  J C Chang; M Lesser
Journal:  Am Rev Respir Dis       Date:  1984-01

7.  Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome.

Authors:  C T Lee; A M Fein; M Lippmann; H Holtzman; P Kimbel; G Weinbaum
Journal:  N Engl J Med       Date:  1981-01-22       Impact factor: 91.245

8.  Lung inflammation induced by complement-derived chemotactic fragments in the alveolus.

Authors:  J O Shaw; P M Henson; J Henson; R O Webster
Journal:  Lab Invest       Date:  1980-05       Impact factor: 5.662

9.  Indomethacin blunts ethchlorvynol-induced pulmonary hypertension but not pulmonary edema.

Authors:  F L Glauser; R P Fairman; J E Millen; R K Falls
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1982-09

10.  Neutrophil alveolitis following endotoxemia. Enhancement by previous exposure to hyperoxia.

Authors:  J E Rinaldo; J H Dauber; J Christman; R M Rogers
Journal:  Am Rev Respir Dis       Date:  1984-12
View more
  1 in total

Review 1.  Bronchoalveolar lavage.

Authors:  W R Martin; P A Padrid; C E Cross
Journal:  Clin Rev Allergy       Date:  1990 Summer-Fall
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.